Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster
- PMID: 20454986
- DOI: 10.1007/s00702-010-0410-y
Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster
Abstract
The pathophysiology of idiopathic dystonias is still unknown, but it is regarded as a basal ganglia disorder. Previous experiments in the dt(sz) hamster, a model of primary paroxysmal dystonia, demonstrated reduced discharge rates and an abnormal pattern within the entopeduncular nucleus (EPN), a basal ganglia output structure. To clarify if this is based on abnormal gamma-aminobutyric acid(GABA)ergic or glutamatergic input, microinjections into the EPN were done in mutant hamsters in the present study. The GABA(A) receptor antagonists pentylenetetrazole and bicuculline exerted moderate antidystonic effects, while previous systemic administrations worsened dystonia in the dt(sz) mutant. GABA-potentiating drugs, i.e., the GABA(A) receptor agonist muscimol and the GABA transporter inhibitor 1,2,5,6-tetrahydro-1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-3-pyridinecarboxy-lic acid (NNC-711), which are known to improve dystonia after systemic treatment in mutant hamsters, did not exert significant effects after EPN injections, but NNC-711 tended to increase the severity at the highest dose (2.5 ng bilateral). The NMDA receptor antagonist D(-)-2-amino-5-phosphopentanoic acid (AP-5) retarded the onset of a dystonic attack. However, this effect was not dose dependent and the AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzol(f)quinoxaline (NBQX) alone or in combination with AP-5 and NNC-711, also failed to show any effects on dystonia. The present data do not provide clear evidence for an enhanced striatal GABAergic input or a reduced glutamatergic activation of the EPN via the subthalamic nucleus, i.e., more pronounced antidystonic effects of GABA(A) receptor antagonists and stronger prodystonic effects of GABAmimetics and glutamate receptor antagonists were expected. Nevertheless, previously found changes in entopeduncular activity probably play a critical pathophysiological role in dystonic hamsters.
Similar articles
-
Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant.Eur J Pharmacol. 2007 Jun 1;563(1-3):102-8. doi: 10.1016/j.ejphar.2007.01.067. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17349621
-
Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.Exp Neurol. 2014 Nov;261:677-84. doi: 10.1016/j.expneurol.2014.08.012. Epub 2014 Aug 17. Exp Neurol. 2014. PMID: 25139804
-
Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.J Neurosci. 2000 Sep 15;20(18):7052-8. doi: 10.1523/JNEUROSCI.20-18-07052.2000. J Neurosci. 2000. PMID: 10995851 Free PMC article.
-
Pathology of idiopathic dystonia: findings from genetic animal models.Prog Neurobiol. 1998 Apr;54(6):633-77. doi: 10.1016/s0301-0082(97)00089-0. Prog Neurobiol. 1998. PMID: 9560845 Review.
-
Animal models for dystonia.Mov Disord. 2013 Jun 15;28(7):982-9. doi: 10.1002/mds.25526. Mov Disord. 2013. PMID: 23893454 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical